GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,942.00
+14.50 (0.75%)
Aug 11, 2026, 11:26 AM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 77.24 billion as of August 11, 2026. Its market cap has increased by 39.45% in one year.
Market Cap
77.24B
Enterprise Value
91.95B
Revenue
33.20B
Ranking
n/a
PE Ratio
16.36
Stock Price
1,942.00
ChartMarket Cap Chart
Since April 12, 2000, GSK plc's market cap has increased from 67.16B to 77.24B, an increase of 15.00%. That is a compound annual growth rate of 0.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 78.56B | 7.32% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 184.51B |
| Haleon | 32.54B |
| Smith & Nephew | 9.36B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.60B |
| Genus | 1.54B |
| Oxford Nanopore Technologies | 1.22B |